Article Type
Changed
Tue, 05/21/2019 - 12:21
Display Headline
BEST PRACTICES IN: Treating Rosacea - A Focus on Azelaic Acid

 

A supplement to Family Practice News. This supplement was sponsored by Intendis, Inc.
Written by Ruth Williams, Medical Writer, and Medisys Health Communications, LLC, on behalf of Intendis, Inc.


Topics
Faculty/Faculty Disclosures


To view the supplement, click the image above.


Topics

• Rosacea: A Common, Chronic Condition

• Treatment Essentials

• Azelaic Acid

• Efficacy

• Combination With Systemic Therapy

• Tolerability

• AzA in Practice

Faculty/Faculty Disclosure

Hilary E. Baldwin, MD
Associate Professor of Dermatology
SUNY-Brooklyn
Brooklyn, New York
Dr Baldwin is a Consultant/Advisory Board/ Speakers' Bureau member of Allergan, Inc., Coria Laboratories Ltd, Galderma Laboratories, L.P., GlaxoSmithKline, Intendis, Inc., Medicis Pharmaceutical Corporation, OrthoNeutrogena, Ranbaxy Pharmaceuticals, sanofi-aventis, and Stiefel Laboratories.


Copyright © 2010 Elsevier Inc.

Article PDF
Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

 

A supplement to Family Practice News. This supplement was sponsored by Intendis, Inc.
Written by Ruth Williams, Medical Writer, and Medisys Health Communications, LLC, on behalf of Intendis, Inc.


Topics
Faculty/Faculty Disclosures


To view the supplement, click the image above.


Topics

• Rosacea: A Common, Chronic Condition

• Treatment Essentials

• Azelaic Acid

• Efficacy

• Combination With Systemic Therapy

• Tolerability

• AzA in Practice

Faculty/Faculty Disclosure

Hilary E. Baldwin, MD
Associate Professor of Dermatology
SUNY-Brooklyn
Brooklyn, New York
Dr Baldwin is a Consultant/Advisory Board/ Speakers' Bureau member of Allergan, Inc., Coria Laboratories Ltd, Galderma Laboratories, L.P., GlaxoSmithKline, Intendis, Inc., Medicis Pharmaceutical Corporation, OrthoNeutrogena, Ranbaxy Pharmaceuticals, sanofi-aventis, and Stiefel Laboratories.


Copyright © 2010 Elsevier Inc.

 

A supplement to Family Practice News. This supplement was sponsored by Intendis, Inc.
Written by Ruth Williams, Medical Writer, and Medisys Health Communications, LLC, on behalf of Intendis, Inc.


Topics
Faculty/Faculty Disclosures


To view the supplement, click the image above.


Topics

• Rosacea: A Common, Chronic Condition

• Treatment Essentials

• Azelaic Acid

• Efficacy

• Combination With Systemic Therapy

• Tolerability

• AzA in Practice

Faculty/Faculty Disclosure

Hilary E. Baldwin, MD
Associate Professor of Dermatology
SUNY-Brooklyn
Brooklyn, New York
Dr Baldwin is a Consultant/Advisory Board/ Speakers' Bureau member of Allergan, Inc., Coria Laboratories Ltd, Galderma Laboratories, L.P., GlaxoSmithKline, Intendis, Inc., Medicis Pharmaceutical Corporation, OrthoNeutrogena, Ranbaxy Pharmaceuticals, sanofi-aventis, and Stiefel Laboratories.


Copyright © 2010 Elsevier Inc.

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: Treating Rosacea - A Focus on Azelaic Acid
Display Headline
BEST PRACTICES IN: Treating Rosacea - A Focus on Azelaic Acid
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media